SWKS
49
11
USB
61
11
ABT
62
5
FITB
60
2
RIG
58
4
AIG
44
6
SO
57
2
ADP
66
2
FDX
40
4
BIIB
28
2
BRK.B
42
2
SRE
66
3
IVZ
48
2
HST
58
18
ROP
59
5
DGX
50
2
JWN
42
2
CRM
65
6
CINF
51
4
PEG
67
5
SWKS
49
11
USB
61
11
ABT
62
5
FITB
60
2
RIG
58
4
AIG
44
6
SO
57
2
ADP
66
2
FDX
40
4
BIIB
28
2
BRK.B
42
2
SRE
66
3
IVZ
48
2
HST
58
18
ROP
59
5
DGX
50
2
JWN
42
2
CRM
65
6
CINF
51
4
PEG
67
5
Financhill
Back

OrganiGram Holdings 10K Form

Sell
19

OGI
OrganiGram Holdings

Last Price:
1.51
Seasonality Move:
19.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OGI News And Ratings

See the #1 stock for the next 7 days that we like better than OGI

OGI Financial Statistics

Sales & Book Value

Annual Sales: $119.77M
Cash Flow: $-3.46M
Price / Cash Flow: 0
Annual Sales: $2.08
Price / Book: 0.73

Profitability

EPS (TTM): -0.84200
Net Income (TTM): $-186.7M
Gross Margin: $28.15M
Return on Equity: -77.24%
Return on Assets: -67.04%

OrganiGram Holdings Earnings Forecast

Key OrganiGram Holdings Financial Ratios

  • The Gross Profit Margin over the past 9 years for OGI is 23.51%.
  • The Selling, General & Administrative Expenses for OGI have been equal to 44.55% of Gross Profit Margin.
  • The Research & Development expenses have been 8.17% of Revenue.
  • The Interest Expense is -0.12% of Operating Income.
  • The Net Earning history of OGI is -153.80% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

OrganiGram Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: OGI
Website: organigram.ca

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.29
Quick Ratio: 2.3

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OGI Technical Analysis vs Fundamental Analysis

Sell
19
OrganiGram Holdings (OGI) is a Sell

Is OrganiGram Holdings a Buy or a Sell?